Ablative Solutions' Series C Round

Ablative Solutions raised a round of funding on March 01, 2017. Investors include BioStar Ventures.

Ablative Solutions (ASI) is developing a different approach to Renal Denervation, a new therapy that addresses hypertension and other diseases related to overactive sympathetic nerve activity. The sym…

Articles about Ablative Solutions' Series C Round: